Literature DB >> 17627737

A mouse model of hypercholesterolemia-induced erectile dysfunction.

Donghua Xie1, Shelly I Odronic, Feihua Wu, Anne M Pippen, Craig F Donatucci, Brian H Annex.   

Abstract

INTRODUCTION: Hypercholesterolemia is one of the most important risk factors for the development of erectile dysfunction (ED) in men. AIM: We employed an established mouse model of hypercholesterolemia. MAIN OUTCOME MEASURES: We test for abnormalities in vasoreactivity in corporal tissue and temporally correlated changes in vasoreactivity with alterations in histology and protein expression.
METHODS: A total of 150 mice were studied. A total of 100 apolipoprotein-E knockout (ApoE(-/-)) mice were fed a 1.25% cholesterol diet for 2, 4, 8, and 12 weeks (N = 25/group), while a group of ApoE(-/-) and wild-type Bl-6 mice were fed a normal diet. The study was terminated, and all mice were harvested at 22 weeks of age for vasoreactivity, histology, and protein studies from corporal tissues. Dose-response curves were generated to evaluate endothelium-dependent and endothelium-independent vasoreactivity, ex vivo. The contents of endothelial cells, smooth muscle cells, and smooth muscle/collagen ratio were assessed by immunohistochemistry staining or Masson staining. Level of cyclic guanosine monophosphate (cGMP) was detected by enzyme immunoassay assay. Levels of phosphorylated endothelial nitric oxide synthase (p-eNOS)/total eNOS, neuronal nitric oxide synthase (nNOS), and cyclic GMP-dependent kinase (cGK-1) protein were assessed by Western analysis.
RESULTS: Abnormalities in endothelium-dependent and endothelium-independent vasoreactivities, endothelial content, smooth muscle/collagen ratio, p-eNOS phosphorylation at Ser1177 only, nNOS, cGMP, and cGK-1 changed with the different durations of the high-cholesterol diet.
CONCLUSIONS: These data demonstrate that this mouse model is suitable for investigating aspects of hypercholesterolemic ED.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17627737     DOI: 10.1111/j.1743-6109.2007.00518.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  12 in total

Review 1.  Pharmacokinetics and Pharmacodynamics of Promising Arginase Inhibitors.

Authors:  Khaled S Abdelkawy; Kelsey Lack; Fawzy Elbarbry
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-06       Impact factor: 2.441

2.  Hypercholesterolemia-induced erectile dysfunction: endothelial nitric oxide synthase (eNOS) uncoupling in the mouse penis by NAD(P)H oxidase.

Authors:  Biljana Musicki; Tongyun Liu; Gwen A Lagoda; Travis D Strong; Sena F Sezen; Justin M Johnson; Arthur L Burnett
Journal:  J Sex Med       Date:  2010-09       Impact factor: 3.802

3.  Arginase II deletion increases corpora cavernosa relaxation in diabetic mice.

Authors:  Haroldo A Toque; Rita C Tostes; Lin Yao; Zhimin Xu; R Clinton Webb; Ruth B Caldwell; R William Caldwell
Journal:  J Sex Med       Date:  2010-11-03       Impact factor: 3.802

4.  Telmisartan, ramipril and their combination improve endothelial function in different tissues in a murine model of cholesterol-induced atherosclerosis.

Authors:  N Schlimmer; M Kratz; M Böhm; M Baumhäkel
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

5.  p38 Mitogen-activated protein kinase (MAPK) increases arginase activity and contributes to endothelial dysfunction in corpora cavernosa from angiotensin-II-treated mice.

Authors:  Haroldo A Toque; Maritza J Romero; Rita C Tostes; Alia Shatanawi; Surabhi Chandra; Zidonia N Carneiro; Edward W Inscho; Robert Clinton Webb; Ruth B Caldwell; Robert William Caldwell
Journal:  J Sex Med       Date:  2010-08-30       Impact factor: 3.802

6.  Erectile dysfunction precedes coronary artery endothelial dysfunction in rats fed a high-fat, high-sucrose, Western pattern diet.

Authors:  Justin D La Favor; Ethan J Anderson; Robert C Hickner; Christopher J Wingard
Journal:  J Sex Med       Date:  2012-11-21       Impact factor: 3.802

7.  Insights into the development and treatment of cardiovascular disease: a role for animal models.

Authors:  Cecil S Thompson
Journal:  Open Cardiovasc Med J       Date:  2010-11-26

Review 8.  Animal models of erectile dysfunction.

Authors:  Snehlata V Gajbhiye; Kshitij S Jadhav; Padmaja A Marathe; Dattatray B Pawar
Journal:  Indian J Urol       Date:  2015 Jan-Mar

9.  A novel method to establish a rat ED model using internal iliac artery ligation combined with hyperlipidemia.

Authors:  Chao Hu; Feixiang Wang; Yehao Dong; Jican Dai
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

10.  Treatment with CB2 agonist JWH-133 reduces histological features associated with erectile dysfunction in hypercholesterolemic mice.

Authors:  Rodrigo Araujo Fraga-Silva; Fabiana Pereira Costa-Fraga; Fabrizio Montecucco; Younouss Faye; Silvia Quintao Savergnini; Sébastien Lenglet; François Mach; Sabine Steffens; Nikolaos Stergiopulos; Robson Augusto Souza dos Santos; Rafaela Fernandes da Silva
Journal:  Clin Dev Immunol       Date:  2013-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.